XML 25 R15.htm IDEA: XBRL DOCUMENT
v3.23.1

Fair Value Measurements | 3 Months Ended
--- | ---
Mar. 31, 2023
Fair Value Measurements [Abstract] |
Fair Value Measurements | Note 8 - Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The Company’s financial instruments are classified as either Level 1, Level 2 or Level 3. These tiers include:
| ● | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
| ● | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
| ● | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
The following tables present information about the Company’s assets and liabilities that are measured at fair value on March 31, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
|  | March 31, 2023 |  |  | Quoted Prices In Active Markets (Level 1) |  |  | Significant Other Observable Inputs (Level 2) |  |  | Significant Other Unobservable Inputs (Level 3) |
Assets: |  |  |  |  |  |  |  |  |  |  |  |
Cash and marketable securities held in trust |  | $ | 10,392,055 |  |  | $ | 10,392,055 |  |  |  | — |  |  |  | — |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant liabilities – Public Warrants |  | $ | 759,000 |  |  | $ | 759,000 |  |  | $ | — |  |  | $ | — |
Warrant liabilities – Private Placement Warrants |  |  | 624,538 |  |  |  | — |  |  |  | — |  |  |  | 624,538 |
Warrant liabilities – Representative’s Warrants |  |  | 48,386 |  |  |  | — |  |  |  | — |  |  |  | 48,386 |
Total |  | $ | 1,431,924 |  |  | $ | 759,000 |  |  | $ | — |  |  | $ | 672,924 |
|  | December 31, 2022 |  |  | Quoted Prices In Active Markets (Level 1) |  |  | Significant Other Observable Inputs (Level 2) |  |  | Significant Other Unobservable Inputs (Level 3) |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Warrant liabilities – Public Warrants |  | $ | 450,656 |  |  | $ | 450,656 |  |  | $ | — |  |  | $ | — |
Warrant liabilities – Private Placement Warrants |  |  | 377,857 |  |  |  | — |  |  |  | — |  |  |  | 377,857 |
Warrant liabilities – Representative’s Warrants |  |  | 29,274 |  |  |  | — |  |  |  | — |  |  |  | 29,274 |
Total |  | $ | 857,787 |  |  | $ | 450,656 |  |  | $ | — |  |  | $ | 407,131 |
The Company did not have any assets in the Trust Account measured at fair value as of December 31, 2022. The Public Warrants, the Private Placement Warrants and the Representative’s Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within liabilities on the condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the unaudited condensed consolidated statements of operations. The Company utilized a Monte Carlo simulation model for the initial valuation of the Public Warrants. The subsequent measurement of the Public Warrants at March 31, 2023 and December 31, 2022 was classified as Level 1 due to the use of an observable market quote in an active market. As of March 31, 2023 and December 31, 2022, the aggregate value of Public Warrants was $759,000 and $450,656, respectively. The Company uses a Monte Carlo simulation model to value the Private Placement Warrants and the Representative’s Warrants. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one shares of Common Stock and one-half of one Public Warrant) and (ii) the sale of Private Placement Warrants, first to the warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to Common Stock subject to possible redemption (temporary equity) based on their relative fair values at the initial measurement date. The Private Placement Warrants and the Representative’s Warrants were classified within Level 3 of the fair value hierarchy at the measurement dates due to the use of unobservable inputs. Inherent in pricing models are assumptions related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates the volatility of its common stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The key inputs into the Monte Carlo simulation model for the warrant liabilities were as follows at March 31, 2023 and December 31, 2022:
|  | March 31, 2023 |  |  | December 31, 2022 |
Input |  |  |  |  |  |
Risk-free interest rate |  |  | 4.76 | % |  |  | 4.74 | %
Expected term (years) |  |  | .80 |  |  |  | .90 |
Expected volatility |  |  | 8.4 | % |  |  | 7.7 | %
Exercise price |  | $ | 11.50 |  |  | $ | 11.50 |
Fair value of Common stock |  | $ | 10.34 |  |  | $ | 10.13 |
The following table provides a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis for the three months ended March 31, 2023 and 2022:
|  | Private Placement Warrants |  |  | Public Warrants |  |  | Representative’s Warrants |  |  | Warrant Liability |
Fair value at December 31, 2022 |  | $ | 377,857 |  |  | $ | — |  |  | $ | 29,274 |  |  | $ | 407,131 |
Change in fair value of warrant liabilities |  |  | 246,681 |  |  |  | — |  |  |  | 19,112 |  |  |  | 265,793 |
Fair value at March 31, 2023 |  | $ | 624,538 |  |  | $ | — |  |  | $ | 48,386 |  |  | $ | 672,924 |
|  | Private Placement Warrants |  |  | Public Warrants |  |  | Representative’s Warrants |  |  | Warrant Liability |
Fair value at December 31, 2021 |  | $ | 3,086,701 |  |  | $ | 3,890,177 |  |  | $ | 239,144 |  |  | $ | 7,216,022 |
Change in fair value of warrant liabilities |  |  | (1,660,759 | ) |  |  | (2,088,501 | ) |  |  | (128,669 | ) |  |  | (3,877,929 | )
Transfer out of Level 3 to Level 1 |  |  | — |  |  |  | (1,801,676 | ) |  |  | — |  |  |  | (1,801,676 | )
Fair value at March 31, 2022 |  | $ | 1,425,942 |  |  | $ | — |  |  | $ | 110,475 |  |  | $ | 1,536,417 |
Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period. There was a transfer out of Level 3 to Level 1 for the fair value of the Public Warrants when they began to trade separately from the Units during the three months ended March 31, 2022.

X
- References No definition available. + Details
Name: | nvac_FairValueMeasurementsLineItems
Namespace Prefix: | nvac_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration